These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 16278393

  • 1. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study.
    Schmiemann V, Böcking A, Kazimirek M, Onofre AS, Gabbert HE, Kappes R, Gerharz CD, Grote HJ.
    Clin Cancer Res; 2005 Nov 01; 11(21):7728-34. PubMed ID: 16278393
    [Abstract] [Full Text] [Related]

  • 2. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ, Schmiemann V, Geddert H, Bocking A, Kappes R, Gabbert HE, Sarbia M.
    Cancer; 2006 Apr 25; 108(2):129-34. PubMed ID: 16444703
    [Abstract] [Full Text] [Related]

  • 3. [Aberrant promoter methylation as biomarker for molecular cytological diagnosis of lung cancer].
    Grote HJ.
    Verh Dtsch Ges Pathol; 2006 Apr 25; 90():216-26. PubMed ID: 17867600
    [Abstract] [Full Text] [Related]

  • 4. Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer.
    Grote HJ, Schmiemann V, Geddert H, Rohr UP, Kappes R, Gabbert HE, Böcking A.
    Int J Cancer; 2005 Sep 20; 116(5):720-5. PubMed ID: 15849750
    [Abstract] [Full Text] [Related]

  • 5. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D.
    Clin Cancer Res; 2003 Apr 20; 9(4):1370-5. PubMed ID: 12684406
    [Abstract] [Full Text] [Related]

  • 6. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.
    Cancer Res; 2002 Apr 15; 62(8):2370-7. PubMed ID: 11956099
    [Abstract] [Full Text] [Related]

  • 7. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.
    Carcinogenesis; 2008 Sep 15; 29(9):1845-9. PubMed ID: 18632757
    [Abstract] [Full Text] [Related]

  • 8. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.
    Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H, Tanimoto M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1219-25. PubMed ID: 15709192
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC.
    Cancer; 2007 Nov 01; 110(9):2019-26. PubMed ID: 17876837
    [Abstract] [Full Text] [Related]

  • 10. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
    Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.
    Int J Oncol; 2001 Aug 01; 19(2):277-81. PubMed ID: 11445839
    [Abstract] [Full Text] [Related]

  • 11. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G.
    Clin Cancer Res; 2002 Dec 01; 8(12):3782-7. PubMed ID: 12473590
    [Abstract] [Full Text] [Related]

  • 12. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 13. DNA methylation markers and early recurrence in stage I lung cancer.
    Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG.
    N Engl J Med; 2008 Mar 13; 358(11):1118-28. PubMed ID: 18337602
    [Abstract] [Full Text] [Related]

  • 14. Promoter hypermethylation of resected bronchial margins: a field defect of changes?
    Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, Yang SC, Baylin SB, Herman JG, Brock MV.
    Clin Cancer Res; 2004 Aug 01; 10(15):5131-6. PubMed ID: 15297416
    [Abstract] [Full Text] [Related]

  • 15. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 17. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
    Ilse P, Biesterfeld S, Pomjanski N, Wrobel C, Schramm M.
    Cancer Genomics Proteomics; 2014 Aug 01; 11(5):251-8. PubMed ID: 25331797
    [Abstract] [Full Text] [Related]

  • 18. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 19. Aberrant methylation of the adenomatous polyposis coli promoter 1A in bronchial aspirates from patients with suspected lung cancer.
    Grote HJ, Schmiemann V, Kiel S, Böcking A, Kappes R, Gabbert HE, Sarbia M.
    Int J Cancer; 2004 Jul 10; 110(5):751-5. PubMed ID: 15146565
    [Abstract] [Full Text] [Related]

  • 20. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.
    Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF.
    Cancer; 2004 Apr 01; 100(7):1472-7. PubMed ID: 15042681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.